Loading organizations...
§ Private Profile · Torino, Piemonte, Italy
Targeting metabolic diseases with non-coding RNA drug therapies.
Resalis Therapeutics has raised $21.6M across 2 funding rounds.
Resalis Therapeutics has raised $21.6M in total across 2 funding rounds.
Resalis Therapeutics has raised $21.6M across 2 funding rounds. Most recently, it raised $10.9M Series A in January 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 4, 2024 | $10.9M Series A | Claus A. Andersson | Pietro Puglisi | Announced |
| Feb 22, 2023 | $10.6M Seed | Pietro Puglisi | Club Degli Investitori, Italian Angels For Growth | Announced |
Resalis Therapeutics has raised $21.6M in total across 2 funding rounds.
Resalis Therapeutics's investors include Claus A. Andersson, Pietro Puglisi, Club degli Investitori, Italian Angels for Growth.